249 related articles for article (PubMed ID: 20305685)
1. The enigmatic processing and secretion of interleukin-33.
Zhao W; Hu Z
Cell Mol Immunol; 2010 Jul; 7(4):260-2. PubMed ID: 20305685
[TBL] [Abstract][Full Text] [Related]
2. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.
Lüthi AU; Cullen SP; McNeela EA; Duriez PJ; Afonina IS; Sheridan C; Brumatti G; Taylor RC; Kersse K; Vandenabeele P; Lavelle EC; Martin SJ
Immunity; 2009 Jul; 31(1):84-98. PubMed ID: 19559631
[TBL] [Abstract][Full Text] [Related]
3. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G.
Lefrançais E; Roga S; Gautier V; Gonzalez-de-Peredo A; Monsarrat B; Girard JP; Cayrol C
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1673-8. PubMed ID: 22307629
[TBL] [Abstract][Full Text] [Related]
4. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1.
Cayrol C; Girard JP
Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9021-6. PubMed ID: 19439663
[TBL] [Abstract][Full Text] [Related]
5. Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.
Rostan O; Arshad MI; Piquet-Pellorce C; Robert-Gangneux F; Gangneux JP; Samson M
Infect Immun; 2015 May; 83(5):1738-48. PubMed ID: 25712928
[TBL] [Abstract][Full Text] [Related]
6. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members.
Lefrançais E; Cayrol C
Eur Cytokine Netw; 2012; 23(4):120-7. PubMed ID: 23306193
[TBL] [Abstract][Full Text] [Related]
8. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils.
Cherry WB; Yoon J; Bartemes KR; Iijima K; Kita H
J Allergy Clin Immunol; 2008 Jun; 121(6):1484-90. PubMed ID: 18539196
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-33 in allergy.
Ohno T; Morita H; Arae K; Matsumoto K; Nakae S
Allergy; 2012 Oct; 67(10):1203-14. PubMed ID: 22913600
[TBL] [Abstract][Full Text] [Related]
10. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Schmitz J; Owyang A; Oldham E; Song Y; Murphy E; McClanahan TK; Zurawski G; Moshrefi M; Qin J; Li X; Gorman DM; Bazan JF; Kastelein RA
Immunity; 2005 Nov; 23(5):479-90. PubMed ID: 16286016
[TBL] [Abstract][Full Text] [Related]
11. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.
Carriere V; Roussel L; Ortega N; Lacorre DA; Americh L; Aguilar L; Bouche G; Girard JP
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):282-7. PubMed ID: 17185418
[TBL] [Abstract][Full Text] [Related]
12. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.
Kamekura R; Kojima T; Takano K; Go M; Sawada N; Himi T
Clin Exp Allergy; 2012 Feb; 42(2):218-28. PubMed ID: 22233535
[TBL] [Abstract][Full Text] [Related]
13. Special aspects of interleukin-33 and the IL-33 receptor complex.
Martin MU
Semin Immunol; 2013 Dec; 25(6):449-57. PubMed ID: 24230466
[TBL] [Abstract][Full Text] [Related]
14. The role of interleukin-33 in rhinitis.
Rogala B; Glück J
Curr Allergy Asthma Rep; 2013 Apr; 13(2):196-202. PubMed ID: 23381303
[TBL] [Abstract][Full Text] [Related]
15. IL-33: a sheep in wolf's clothing?
Gadina M; Jefferies CA
Sci STKE; 2007 Jun; 2007(390):pe31. PubMed ID: 17565120
[TBL] [Abstract][Full Text] [Related]
16. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.
Pecaric-Petkovic T; Didichenko SA; Kaempfer S; Spiegl N; Dahinden CA
Blood; 2009 Feb; 113(7):1526-34. PubMed ID: 18955562
[TBL] [Abstract][Full Text] [Related]
17. Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation.
Chow JY; Wong CK; Cheung PF; Lam CW
Cell Mol Immunol; 2010 Jan; 7(1):26-34. PubMed ID: 20029461
[TBL] [Abstract][Full Text] [Related]
18. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
Moulin D; Donzé O; Talabot-Ayer D; Mézin F; Palmer G; Gabay C
Cytokine; 2007 Dec; 40(3):216-25. PubMed ID: 18023358
[TBL] [Abstract][Full Text] [Related]
19. Activation of eosinophils by IL-12 family cytokine IL-27: Implications of the pleiotropic roles of IL-27 in allergic responses.
Hu S; Wong CK; Lam CW
Immunobiology; 2011; 216(1-2):54-65. PubMed ID: 20435369
[TBL] [Abstract][Full Text] [Related]
20. Research progress on interleukin-33 and its roles in the central nervous system.
Han P; Mi WL; Wang YQ
Neurosci Bull; 2011 Oct; 27(5):351-7. PubMed ID: 21934731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
